Oxford wins FDA nod for patient-specific cranial system

02/19/2013 | BeckersASC.com

The FDA has given Oxford Performance Materials 510(k) clearance to market its OsteoFab system. The implantable device, which is tailored to each patient, is designed to help replace skull voids caused by disease or trauma.

View Full Article in:

BeckersASC.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN